Mutationally activated Rho GTPases in cancer

Small GTPases

Volumn 4, Issue 3, 2013, Pages

  Alan, Jamie K ^a   Lundquist, Erik A ^b  

^a Central Michigan University College of Medicine   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

C. elegans; Cancer; Rho GTPases

Indexed keywords

GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; H RAS PROTEIN; K RAS PROTEIN; N RAS PROTEIN; PHENYLALANINE; RAC1 PROTEIN; RAS PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE; UNCLASSIFIED DRUG; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR;

AMINO ACID SUBSTITUTION; BREAST CANCER; CAENORHABDITIS ELEGANS; CANCER CELL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CYTOSKELETON; ENZYME ACTIVITY; EXOME; GENE ACTIVATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HUMAN; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS POTENTIAL; MUTAGENESIS; NERVE CELL DIFFERENTIATION; NONHUMAN; ONCOGENE RAS; POINT MUTATION; PROTEIN FAMILY; REVIEW; SEQUENCE ANALYSIS; ANIMAL; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY;

ANIMALS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MUTATION; NEOPLASMS; RAC1 GTP-BINDING PROTEIN; RHO GTP-BINDING PROTEINS; RHO-SPECIFIC GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS;

EID: 84887509401     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: 10.4161/sgtp.26530     Document Type: Review

References (51)

1. Wennerberg K, Rossman KL, Der CJ. The Ras superfamily at a glance. J Cell Sci 2005; 118:843-846; P M I D: 15 7 310 01; http://dx.doi.org/10.1242/ jcs.01660
2. Wennerberg K, Der CJ. Rho-family GTPases: it's not only Rac and Rho (and I like it). J Cell Sci 2004; 117:1301-1312; PM ID:15 0 2 0 670; http://dx.doi. org/10.124 2 /j c s. 01118
3. Wherlock M, Mellor H. The Rho GTPase family: a Racs to Wrchs story. J Cell Sci 2002; 115:239-240; PM ID:11839775
4. Etienne-Manneville S, Hall A. Rho GTPases in cell biology. Nature 2002; 420:629-635; PMID:12478284; http://dx.doi.org/10.1038/nature01148
5. Ziman M, Preuss D, Mulholland J, O'Brien JM, Botstein D, Johnson DI. Subcellular localization of Cdc42p, a Saccharomyces cerevisiae GTP-binding protein involved in the control of cell polarity. Mol Biol Cell 1993; 4:1307-1316; PM I D: 8167411; http:// dx.doi.org/10.1091/mbc.4.12.1307
6. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21:247-269; PMID:16212495; http://dx.doi.org/10.1146/ annurev.cellbio.21.020604.150721
7. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007; 129:865-877; PMID:17540168; http://dx.doi.org/10.1016/j.cell.2007.05.018
8. DerMardirossian C, Bokoch GM. GDIs: central regulatory molecules in Rho GTPase activation. Trends Cell Biol 2005; 15:356-363; PM I D: 159 219 0 9; http:// dx.doi.org/10.1016/j.tcb.2005.05.001
9. Aspenström P, Fransson A, Saras J. Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 2004; 377:327-337; PM I D: 145215 0 8; http://dx.doi.org/10.1042/ BJ20031041
10. Ridley AJ. Rho proteins and cancer. Breast Cancer Res Treat 2004; 84:13-19; PMID:14999150; http:// dx.doi.org/10.1023/B:BREA.0000018423.47497.c6
11. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011; 39 (Database issue):D945-950; PMID:20952405; http://dx.doi.org/10.1093/nar/ gkq929
12. Fernández-Medarde A, Santos E. Ras in cancer and developmental diseases. Genes Cancer 2011; 2:344 -358; PMID:21779504; http://dx.doi. o r g/10.117 7/ 19 476 019114110 8 4
13. Gaidano G, Pasqualucci L, Capello D, Berra E, Deambrogi C, Rossi D, Maria Larocca L, Gloghini A, Carbone A, Dalla-Favera R. Aberrant somatic hyper-mutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 2003; 102:1833-1841; PMID:12714522; http://dx.doi.org/10.1182/ blood-2002-11-3606
14. Preudhomme C, Roumier C, Hildebrand MP, Dallery-Prudhomme E, Lantoine D, Laï JL, Daudignon A, Adenis C, Bauters F, Fenaux P, et al. Nonrandom 4p13 rearrangements of the RhoH/ TTF gene, encoding a GTP-binding protein, in non-Hodgkin's lymphoma and multiple myeloma. Oncogene 2000; 19:2023-2032; PMID:10803463; http://dx.doi.org/10.1038 /sj.onc.1203521
15. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 2002; 87:635-644; PMID:12237774; http://dx.doi.org/10.1038/ sj.bjc.6600510
16. Fritz G, Just I, Kaina B. Rho GTPases are over-expressed in human tumors. Int J Cancer 1999; 81:682-687; PMID:10328216; http://dx.doi.org/10.1002/ (SICI)1097-0215(19990531)81:5 682::AID-IJC23.0.CO;2-B
17. van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer pheno-type. Cancer Res 2000; 60:5832-5838; PMID:11059780
18. Hwang SL, Lieu AS, Chang JH, Cheng TS, Cheng CY, Lee KS, Lin CL, Howng SL, Hong YR. Rac2 expression and mutation in human brain tumors. Acta Neurochir (Wien) 2005; 147:551-554, discussion 554; PMID:15812594; http://dx.doi.org/10.1007/ s00701-005-0515-5
19. Culig Z, Bartsch G. Androgen axis in prostate cancer. J Cell Biochem 2006; 99:373-381; PMID:16598769; http://dx.doi.org/10.1002/jcb.20898
20. Kirikoshi H, Katoh M. Expression of WRCH1 in human cancer and down-regulation of WRCH1 by beta-estradiol in MCF-7 cells. Int J Oncol 2002; 20:777-783; PMID:11894124
21. Gouw LG, Reading NS, Jenson SD, Lim MS, Elenitoba-Johnson KS. Expression of the Rho-family GTPase gene RHOF in lymphocyte subsets and malignant lymphomas. Br J Haematol 2005; 129:531-533; PMID:15877735; http://dx.doi. or g /10.1111 /j.1 3 65 -2141. 2 0 05.0 5 4 81. x
22. nd, Azuma T, Mercer H, Sugarbaker DJ, Kwiatkowski DJ. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gel-solin expression. Cancer 1999; 85:47-57; PMID:9921973; http://dx.doi.org/10.1002/ (SICI)1097- 0142 (19990101) 85:147:: A ID-CNCR73.0.CO;2-L
23. Liu SY, Yen CY, Yang SC, Chiang WF, Chang KW. Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma. J Oral Maxillofac Surg 2004; 62:702-707; P M I D: 15170 2 8 2; http://dx.doi.org/10.1016/j.joms.2004.02.002
24. Kamai T, Yamanishi T, Shirataki H, Takagi K, Asami H, Ito Y, Yoshida K. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin Cancer Res 2004; 10:4799-805; PM I D: 15 2 69155; http://dx.doi. org/10.1158/1078-0432.CCR-0436-03
25. Pan Y, Bi F, Liu N, Xue Y, Yao X, Zheng Y, Fan D. Expression of seven main Rho family members in gastric carcinoma. Biochem Biophys Res Commun 2004; 315:686-91; PMID:14975755; http://dx.doi. org/10.1016/j.bbrc.2004.01.108
26. Abraham MT, Kuriakose MA, Sacks PG, Yee H, Chiriboga L, Bearer EL, Delacure MD. Motility-related proteins as markers for head and neck squamous cell cancer. Laryngoscope 2001; 111:1285 -1289; PMID:11568556; http://dx.doi. org/10.1097/00005537-200107000-00027
27. Kamai T, Kawakami S, Koga F, Arai G, Takagi K, Arai K, Tsujii T, Yoshida KI. RhoA is associated with invasion and lymph node metastasis in upper urinary tract cancer. BJU Int 2003; 91:234-8;PM ID:12581011; http://dx.doi. org/10.1046/j.1464-410X.2003.03063.x
28. Kamai T, Arai K, Tsujii T, Honda M, Yoshida K. Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int 2001; 87:227-31; PMID:11167647; http://dx.doi. org/10.1046/j.1464-410x.2001.02030.x
29. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994; 77:537-49; PMID:7999144; http://dx.doi. org/10.1016/0092-8674(94)90216-X
30. Adams HC, Chen R, Liu Z, Whitehead IP. Regulation of breast cancer cell motility by T-cell lymphoma invasion and metastasis-inducing protein. Breast Cancer Res 2010; 12:R69; PMID:20819206; http://dx.doi.org/10.1186/bcr2637
31. Wu D, Asiedu M, Wei Q. Myosin-interacting gua-nine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Oncogene 2009; 28:2219-30;PMID:194 2114 4; http://dx.doi. org/10.1038/onc.2009.96
32. Qin J, Xie Y, Wang B, Hoshino M, Wolff DW, Zhao J, Scofield MA, Dowd FJ, Lin MF, Tu Y. Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene 2009; 28:1853-63;PMID:19305425; http://dx.doi. org/10.1038/onc.2009.30
33. Wolf RM, Draghi N, Liang X, Dai C, Uhrbom L, Eklöf C, Westermark B, Holland EC, Resh MD. P190rhogap can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev 2003; 17: 476 -87; PMID:12600941; http://dx.doi. org/10.1101/gad.1040003
34. Ching Y P, Wong CM, Chan SF, Leung TH, Ng DC, Jin DY, Ng IO. Deleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocel-lular carcinoma. J Biol Chem 2003; 278:10824-30; PM I D:125318 8 7; http://d x.doi.org/10.1074/jbc. M208310200
35. Forget MA, Desrosiers RR, Del M, Moumdjian R, Shedid D, Berthelet F, Béliveau R. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin Exp Metastasis 2002; 19:9-15; PM ID:11918088; http:// dx.doi.org/10.1023/A:1013884426692
36. Jiang WG, Watkins G, Lane J, Cunnick GH, Douglas-Jones A, Mokbel K, Mansel RE. Prognostic value of rho GTPases and rho guanine nucleotide dissociation inhibitors in human breast cancers. Clin Cancer Res 2003; 9:6432-40; PMID:14695145
37. rd. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2002; 2:76-84; PMID:11788994; http://dx.doi. org/10.1002/1615-9861(200201)2:176::AID-PROT763.0.CO;2-O
38. Stevens EV, Banet N, Onesto C, Plachco A, Alan JK, Nikolaishvili-Feinberg N, Midkiff BR, Kuan PF, Liu J, Miller CR, et al. RhoGDI2 antagonizes ovarian carcinoma growth, invasion and metastasis. Small GTPases 2011; 2:202-10; PMID:22145092; http:// dx.doi.org/10.4161/sgtp.2.4.17795
39. Zhao L, Wang H, Li J, Liu Y, Ding Y. Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 2008; 7:3994-4003; PMID:18651761; http://dx.doi.org/10.1021/ pr800271b
40. Zhao L, Wang H, Sun X, Ding Y. Comparative pro-teomic analysis identifies proteins associated with the development and progression of colorectal carcinoma. FEBS J 2010; 277:4195-204; PMID:20812987; http: //dx.doi.org /10.1111/j.1742 - 4 658.2010.07808.x
41. Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker J P, Cheng E, Davis MJ, Goh G, Choi M, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44:1006-14; PMID:22842228; http:// dx.doi.org/10.1038/ng.2359
42. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, Nickerson E, Auclair D, Li L, Place C, et al. A landscape of driver mutations in melanoma. Cell 2012; 150:251-63; PMID: 22817889; http://dx.doi.org/10.1016/j.cell.2012.06.024
43. Malumbres M, Barbacid M. RAS oncogenes: the first 30 years. Nat Rev Cancer 2003; 3:459-65; PMID:12778136; http://dx.doi.org/10.1038/ nrc1097
44. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov G V, Lawrence MS, Sougnez C, McKenna A, et al. The mutational landscape of head and neck squamous cell carcinoma. S c ie n c e 2011; 333: 1157- 60; PM I D: 21798893; http:// dx.doi.org/10.1126/science.1208130
45. Shakir MA, Gill JS, Lundquist EA. Interactions of UNC-34 Enabled with Rac GTPases and the NIK kinase MIG-15 in Caenorhabditis elegans axon path-finding and neuronal migration. Genetics 2006; 172: 893 -913;PMID:16204220; http://dx.doi. org/10.1534/genetics.105.046359
46. Reddien PW, Horvitz HR. CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat Cell Biol 2000; 2:131-6; PMID:10707082; http://dx.doi. org/10.1038/35004000
47. Zipkin ID, Kindt RM, Kenyon CJ. Role of a new Rho family member in cell migration and axon guidance in C. elegans. Cell 1997; 90:883-94;PMID:9298900; http://dx.doi.org/10.1016/S0092-8674(00)80353-0
48. Lundquist EA, Reddien PW, Hartwieg E, Horvitz HR, Bargmann CI. Three C. elegans Rac proteins and several alternative Rac regulators control axon guidance, cell migration and apoptotic cell phagocytosis. Development 2001; 128:4475-88; PM ID:11714 673
49. Shakir MA, Jiang K, Struckhoff EC, Demarco RS, Patel FB, Soto MC, Lundquist EA. The Arp2/3 activators WAVE and WASP have distinct genetic interactions with Rac GTPases in Caenorhabditis elegans axon guidance. Genetics 2008; 179:1957-71; PMID:18689885; http://dx.doi.org/10.1534/ genetics.108.088963
50. deBakker CD, Haney LB, Kinchen JM, Grimsley C, Lu M, Klingele D, Hsu PK, Chou BK, Cheng LC, Blangy A, et al. Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO. Curr Biol 2004; 14:2208-16; PM I D: 15 6 2 0 6 47; http://dx.doi.org/10.1016/j.cub.2004.12.029
51. Demarco RS, Struckhoff EC, Lundquist EA. The Rac GTP exchange factor TIAM-1 acts with CDC-42 and the guidance receptor UNC-40/DCC in neuronal protrusion and axon guidance. PLoS Genet 2012; 8: e1002665; PM I D: 2 2570 618; http://dx.doi. org/10.1371/journal.pgen.1002665